INIS
receptors
100%
risks
98%
insulin
90%
patients
88%
humans
88%
women
88%
mice
72%
fats
71%
cholesterol
67%
comparative evaluations
58%
levels
56%
adipose tissue
49%
lipids
48%
glucose
46%
vaccines
45%
men
44%
proteins
44%
liver
43%
adults
42%
concentration
39%
obesity
38%
diseases
36%
plasma
36%
sensitivity
35%
distribution
33%
synthesis
32%
fatty acids
31%
rats
30%
cocaine
29%
india
29%
lipoproteins
29%
females
29%
diet
28%
populations
28%
therapy
27%
density
27%
surveys
27%
control
27%
genetics
26%
usa
26%
cancer
26%
serotonin
25%
data
25%
metabolism
25%
cardiovascular diseases
25%
ethanol
25%
diabetes mellitus
25%
males
24%
alcohol dehydrogenase
23%
deer
23%
evaluation
23%
reviews
22%
inflammation
22%
children
21%
pancreas
21%
communities
21%
interactions
20%
antibodies
20%
oxidation
20%
administration
19%
esters
19%
adolescents
19%
triglycerides
18%
hospitals
18%
weight
18%
dopamine
17%
injuries
17%
chlorides
17%
molecules
17%
doses
16%
phosphodiesterases
16%
uptake
16%
interventions
16%
oil spills
16%
brain
16%
animals
16%
recommendations
15%
values
15%
alcohols
15%
metabolites
14%
neurons
14%
intake
14%
in vitro
14%
pregnancy
14%
feeding
14%
education
13%
drugs
13%
design
13%
thickness
13%
sex
12%
screening
12%
texas
12%
reduction
12%
blood
12%
c-reactive protein
12%
ethnic groups
12%
fasting
12%
sex dependence
11%
polycyclic aromatic hydrocarbons
11%
stem cells
11%
Medicine and Dentistry
Patient
37%
Woman
32%
Asian Indians
29%
Man
26%
Maturity Onset Diabetes of the Young
25%
Wart Virus
23%
Insulin Resistance
22%
Obesity
21%
Age
19%
Diabetes
18%
Hospital
18%
Therapeutic Procedure
15%
Insulin Sensitivity
15%
Vaccine
14%
Inpatient
14%
Fat
13%
Child
13%
Prevalence
12%
Wart Virus Vaccine
12%
Intraperitoneal Fat
12%
Liraglutide
11%
Young Adult
11%
Glucose
10%
Thermal Burn
10%
Body Fat
9%
Body Mass Index
8%
Female
8%
Health
7%
Analysis
7%
Ethnic Group
7%
Male
7%
Experience
7%
Adipose Tissue
7%
Diabetes Mellitus
7%
Papanicolaou Stain
7%
Association
6%
Girl
6%
Young Woman
6%
Malignant Neoplasm
6%
Fat Content
6%
Medicare
6%
Lipid Metabolism
6%
Impaired Fasting Glucose
5%
Hyperhomocysteinemia
5%
Survival
5%
Evaluation Study
5%
Health Care Provider
5%
Cancer Screening
5%
Placebo
5%
Rosuvastatin
5%
Atorvastatin
5%
Ezetimibe/Simvastatin
5%
Bupropion
5%
Sustained Drug Release
5%
Smoking
5%
Diet
5%
Body Fat Distribution
5%
Patient with Type 2 Diabetes
5%
BRCA Mutation
5%
Bisphosphonate
5%
Osteonecrosis of the Jaw
5%
Peripheral Blood Mononuclear Cell
5%
Pancreatic Injury
5%
Intima-Media Thickness
5%
Chronic Pancreatitis
5%
Cystectomy
5%
Alcohol
5%
Total Knee Arthroplasty
5%
Alcohol Dehydrogenase
5%
Fatty Acid Ester
5%
Odds Ratio
5%
Lipid Diet
5%
Disease Predisposition
5%
Immunization
5%
Medical Student
5%
Student
5%
Androgen Therapy
5%
Burn
5%
Androgen Deficiency
5%
Glucose Metabolism
5%
Peroxisome Proliferator Activated Receptor
5%
Bladder Cancer
5%
Health Hazard
5%
Alcoholic Fatty Liver
5%
Bariatric Surgery
5%
Phosphodiesterase I
5%
Nucleotide Pyrophosphatase
5%
White Adipose Tissue
5%
Diagnosis
5%
Abdominal Subcutaneous Fat
5%
Retroperitoneal Fat
5%
Keyphrases
High-density Lipoprotein Cholesterol (HDL-C)
11%
Asian Indians
11%
Obesity
8%
Fatty Acid Ethyl Esters
8%
Insulin Resistance
7%
Indian Men
7%
Weight Gain
7%
Migrants
6%
Alcohol Dehydrogenase
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Cholesterol
6%
Adipose Tissue
6%
Feeding Model
6%
High-fat Diet
5%
Sterol Metabolism
5%
Angiotensin Receptor Blockade
5%
Sensitivity Function
5%
Risk Variants
5%
Dichloroacetyl Chloride
5%
Galveston Bay
5%
Cornu Ammonis
5%
Hippocampal Synapses
5%
Systemic Autoimmune Rheumatic Diseases
5%
Lip Function
5%
Peripheral Adipose Tissues
5%
Carboxylesterase 1 (CES1)
5%
Simvastatin
5%
Cholesterol HDL
5%
Emerging Risk Factors
5%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
5%
Rosuvastatin
5%
Human Papillomavirus Prevalence
5%
Low-density Lipoprotein Cholesterol (LDL-C)
5%
Apolipoprotein B (Apo B)
5%
Ezetimibe
5%
Apolipoprotein A-I (ApoA-I)
5%
Diazepine
5%
Phosphate
5%
Aza-analogue
5%
Upper Body
5%
5-HT2A Receptor
5%
Pharmacological Evaluation
5%
Maternal Experience
5%
Ampakine
5%
Context Discrimination
5%
Synthetic Evaluation
5%
Deer Mice
5%
Pancreatic Injury
5%
Rehospitalization
5%
Lipid Aldehydes
5%
Ethanol Effect
5%
Early-onset Type 2 Diabetes
5%
TRIB3
5%
Ethanol
5%
Perchloroethylene
5%
Proopiomelanocortin Neurons
5%
Low-density Lipids
5%
Homology Modeling
5%
Binge Ethanol
5%
Deepwater Horizon Oil
5%
Citizen Science
5%
Cardiometabolic Complications
5%
Endogenous Neural Stem Cells
5%
Diet-induced
5%
Fishermen Community
5%
Chronic Ethanol
5%
Science Networks
5%
Fishing Communities
5%
Oral Human Papillomavirus
5%
Peripheral Blood Mononuclear Cells
5%
Oleamide Analogues
5%
Fatty Acid Methyl Esters
5%
Liraglutide
5%
Renal Manifestations
5%
Uric Acid Nephrolithiasis
5%
Post-transplant Diabetes Mellitus
5%
GSTP1
5%
Oxycodone Self-administration
5%
Special Populations
5%
Androgen Therapy
5%
Cholesterol Distribution
5%
Dopamine D1 Receptor
5%
Inflammation
5%
Current Therapies
5%
Older Men
5%
Dioxygen
5%
LDL Cholesterol
5%
Role of Government
5%
High-sensitivity C-reactive Protein (hs-CRP)
5%
Fatty Acylation
5%
Maternal Beliefs
5%
Sex-dependent Differences
5%
Retroperitoneal Fat
5%
Macondo
5%
Dopamine D1 Agonists
5%
National Lipid Association
5%
South Asian Men
5%
Future Therapies
5%
Autoimmune
5%
Obesity Risk
5%